Alcohol Metabolism After Sleeve Gastrectomy
Prospective Pathophysiological Evaluation of Alcohol Intake and Metabolism After Sleeve Gastrectomy
1 other identifier
observational
30
1 country
1
Brief Summary
This prospective study aimed to determine the alcohol intake symptoms and alcohol metabolism before and 12 months after sleeve gastrectomy (SG) by evaluating blood alcohol content (BAC) and urinary alcohol metabolite levels against the amount of alcohol consumed to reveal the occurrence of any AUD..
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
August 29, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2019
CompletedFirst Posted
Study publicly available on registry
September 6, 2019
CompletedSeptember 6, 2019
September 1, 2019
1 year
August 29, 2019
September 4, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
blood alcohol content (BAC)
Change in BAC after SG
0, 6 and 12 months
urinary alcohol metabolite
change in alcohol metabolite (ethanol and acetaldehyde) after SG
0 and 12 Months
Secondary Outcomes (1)
alcohol addiction
0, 6 and 12 Months
Study Arms (1)
Obese
30 obese patients (12 M/ 18 F) with a mean BMI of 46 candidate to SG Alcohol drink mean volume: 158 Ml administered in 10 minutes
Interventions
Eligibility Criteria
Obese, normal drinker
You may qualify if:
- Age ≥ 21 ≤ 60 years
- BMI ≥ 35 ≤49 Kg/m2
- Candidate to LSG
- Accepts to scheduled follow-up scheme
You may not qualify if:
- Non-drinker
- Previous history of alcoholism
- DMTII
- Hepatic cirrhosis, Nonalcoholic steatohepatitis (NASH) or HCV hepatitis/cirrhosis
- Previous resective gastro-intestinal surgery
- Cholelithiasis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Roma La Sapienzalead
- Azienda vinicola Casal del Gigliocollaborator
Study Sites (1)
University of Rome "la sapienza"
Latina, 04100, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Angelo A Iossa
University of Roma La Sapienza
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
August 29, 2019
First Posted
September 6, 2019
Study Start
January 1, 2018
Primary Completion
January 1, 2019
Study Completion
August 30, 2019
Last Updated
September 6, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share